Fasting glucagon as an independent risk indicator for CAD in patient with type 2 diabetes

Elevated fasting glucagon is an independent risk indicator for CAD in women with T2DM, but not in men. These findings highlight the potential value of glucagon monitoring in T2DM management, especially for women, and support exploring glucagon-pathway-targeted therapies to reduce cardiovascular complications.

Institutions

Tianjin Medical University General Hospital (CN)

Publication Details

Journal: Frontiers in Endocrinology
Published: 2025-12-11
DOI: https://doi.org/10.3389/fendo.2025.1749418
Primary Topic: Diabetes Treatment and Management
Type: article
Field-Weighted Citation Impact: 0.00

Funders

Tianjin Medical University

Controls

|||

ALL TIME

JAN

FEB

MAR

APR

MAY

JUN

JUL

AUG

SEP

OCT

article

Fasting glucagon as an independent risk indicator for CAD in patient with type 2 diabetes

Dec 11, 2025

Frontiers in Endocrinology

Diabetes Treatment and Management

article

Fasting glucagon as an independent risk indicator for CAD in patient with type 2 diabetes

December 11, 2025article en

Abstract

Frontiers in EndocrinologyVol. 16

Tianjin Medical University General Hospital (CN)

Tianjin Medical University

Good health and well-being

Openalex Percentile: Top 33%

Diabetes Treatment and Management

DOI Open Access PDF OpenAlex

AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Fasting glucagon as an independent risk indicator for CAD in patient with type 2 diabetes · Frontiers in Endocrinology (2025) | TGRS Research Map | TGRS